Top compounds associated with response to IRF6


Feature Type Standardized
Nominal ANOVA
mRNA lapatinib CCLE pan-cancer AAC 0.41 2e-13
mRNA Erlotinib CCLE pan-cancer AAC 0.39 3e-12
mRNA Gefitinib CTRPv2 pan-cancer AAC 0.31 2e-11
mRNA erlotinib:PLX-4032 (2:1 mol/mol) CTRPv2 pan-cancer AAC 0.31 1e-10
mRNA Erlotinib CTRPv2 pan-cancer AAC 0.28 2e-10
mRNA lapatinib CTRPv2 pan-cancer AAC 0.27 3e-09
mRNA BIBW2992 CTRPv2 pan-cancer AAC 0.27 6e-09
mRNA Gefitinib GDSC1000 pan-cancer AAC 0.25 2e-08
mRNA canertinib CTRPv2 pan-cancer AAC 0.26 2e-08
mRNA neratinib CTRPv2 pan-cancer AAC 0.25 6e-08
Download CSV